PreciseDx Revenue and Competitors
Estimated Revenue & Valuation
- PreciseDx's estimated annual revenue is currently $1.7M per year.
- PreciseDx's estimated revenue per employee is $70,833
Employee Data
- PreciseDx has 24 Employees.
- PreciseDx grew their employee count by -8% last year.
PreciseDx's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and CTO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP, Commercial Development | Oncology A.I. Dx | Reveal Email/Phone |
4 | VP Commercial Development | Reveal Email/Phone |
5 | Chief Scientific Officer and Founder | Reveal Email/Phone |
6 | Co-Founder and Chief Scientific Officer | Reveal Email/Phone |
7 | Co-Founder and Chief Medical Officer | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Senior Director Strategic Partnerships | Reveal Email/Phone |
10 | Senior Software Engineer | Reveal Email/Phone |
PreciseDx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 63 | 26% | N/A | N/A |
#2 | $1.7M | 51 | 28% | N/A | N/A |
#3 | N/A | 44 | 52% | N/A | N/A |
#4 | N/A | 31 | 48% | N/A | N/A |
#5 | N/A | 47 | 0% | N/A | N/A |
#6 | N/A | 59 | 44% | N/A | N/A |
#7 | N/A | 199 | 24% | N/A | N/A |
#8 | N/A | 82 | 37% | N/A | N/A |
#9 | N/A | 88 | 31% | N/A | N/A |
#10 | N/A | 50 | -2% | N/A | N/A |
What Is PreciseDx?
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology features, enabling better and more personalized treatment and outcomes. Clinical teams can rely on PreciseDx for unmatched insights and actionable intelligence in determining the best treatment for each patient.
keywords:N/AN/A
Total Funding
24
Number of Employees
$1.7M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.5M | 24 | 0% | N/A |
#2 | $5.7M | 24 | -14% | N/A |
#3 | $1.7M | 24 | -14% | $3.3M |
#4 | $2.4M | 24 | N/A | N/A |
#5 | $1.7M | 24 | 20% | $7.8M |